Effect of Immunosuppressive Treatment on Carotid Atherosclerosis in Renal Transplant Recipients

• Atherosclerotic plaques are more frequent in kidney transplant recipients treated with mTORi than those treated with CNI.
• Coronary artery disease and myocardial infarctions are more frequent in kidney transplant recipients treated with mTORi than those treated with CNI.
• mTORi are not better than CNI in terms of influence on cardiovascular risk in kidney transplant recipients.

BackgroundThe aim of this study was to compare the effect of immunosuppressive regimens using either mammalian target of rapamycin inhibitors (mTORi) or calcineurin inhibitors (CNI) on the risk of atherosclerosis in renal transplant patients.Materials and MethodsThe study involved a group of 24 recipients treated with mTORi (mTORi group) and a group of 20 recipients treated with immunosuppressive regimen based on CNI (CNI group). Laboratory and clinical markers of cardiovascular risk in both groups were investigated. Carotid atherosclerosis was evaluated by measurement of the intima media thickness (IMT) of the common and internal carotid artery walls and detection of carotid plaques by a high-resolution ultrasonography. The study was performed 3–24 years after transplantation.ResultsThe mTORi group showed higher level of total cholesterol (242 vs 201 mg/dL; P < .004), low-density lipoprotein cholesterol (140 vs 116 mg/dL; P < .05), and triglycerides (226 vs 168 mg/dL; P < .01). Posttransplant diabetes developed in 34% of mTORi group compared with 25% in the CNI group. The mean of IMT (left and right) of common and internal carotid arteries was similar in both groups. Carotid plaques were detected in 46% of patients from the mTORi group and 25% from CNI group (P < .02). The presence of carotid plaques combined with an IMT of >0.9 mm were associated with male gender, mTORi treatment (P = .03), and cardiovascular events. The incidence of coronary heart disease was higher in mTORi group than in CNI group (53% vs 20%; P = .03).ConclusionsThere was not beneficial effect of immunosuppressive treatment with mTORi on carotid atherosclerosis in renal transplant patients.